Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia (CORTEX)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03487211|
Recruitment Status : Recruiting
First Posted : April 3, 2018
Last Update Posted : September 20, 2019
Shaheed Zulfiqar Ali Bhutto Medical University
Information provided by (Responsible Party):
DR. MOHAMMAD ALI ARIF, Shaheed Zulfiqar Ali Bhutto Medical University
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Recruiting|
|Estimated Primary Completion Date :||December 2, 2019|
|Estimated Study Completion Date :||December 31, 2019|
Publications of Results:
Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009 Jun;36(6):1304-11. doi: 10.3899/jrheum.081090. Epub 2009 Apr 15.
Wright CL, Mist SD, Ross RL, Jones KD. Duloxetine for the treatment of fibromyalgia. Expert Rev Clin Immunol. 2010 Sep;6(5):745-56. doi: 10.1586/eci.10.64. Review.